New 9-Month pill regimen could tackle Drug-Resistant TB
Disease control
Not yet recruiting
This phase 3 trial tests a 9-month, all-oral combination of four drugs (BLMZ) for people aged 12 and older with rifampicin-resistant tuberculosis. The goal is to see if this shorter regimen leads to a cure without the need for injections. Participants take the pills daily or week…
Phase: PHASE3 • Sponsor: Beijing Chest Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC